Journal article · 2023 · Open access

A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry

C.S. Laddha, Ankita Shelke, Y.V. Vaidya, A.A. Sheikh, Kailas R. Biyani

Asian Journal of Pharmaceutical Research and Development, 11(3), 45–51 · Published 15 June 2023 · DOI 10.22270/ajprd.v11i3.1252

Free PDFView at the publisherCite this paper

In brief

“A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry” is a 2023 journal article by C.S. Laddha and 4 co-authors, published in Asian Journal of Pharmaceutical Research and Development. OpenAlex counts 3 citations as of 15 November 2026, which puts it in the top 9% of works published in 2023 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Asian Journal of Pharmaceutical Research and Development.

Citations
3
Most cited in
2025 (2)
Field-weighted impact
0.26
References
39
Authors
5

Abstract

Introduction: The use of artificial intelligence (AI) in drug discovery and the pharma industry has been rapidly expanding in recent years. AI algorithms can analyze vast amounts of data, identify patterns, and make predictions that can accelerate drug discovery and improve patient outcomes. Methods: AI is being used in various stages of the drug discovery process, from target identification and lead optimization to clinical trials and post-market surveillance. Machine learning algorithms, neural networks, and natural language processing are among the AI techniques used in drug discovery. Results: AI-based drug discovery has already shown promising results, with several drugs in clinical trials or approved for use that were discovered using AI. AI is also being used to improve clinical trial design and patient selection, as well as to monitor adverse drug events and optimize drug dosing. Conclusion: AI has the potential to transform the drug discovery and pharma industry, making drug development faster, more efficient, and more effective. However, there are still challenges that need to be addressed, such as the need for high-quality data and the potential for bias in AI algorithms. Overall, the use of AI in drug discovery and the pharma industry is an exciting and rapidly evolving field that has the potential to improve patient outcomes and revolutionize healthcare.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Laddha, C., Shelke, A., Vaidya, Y., Sheikh, A., & Biyani, K. R. (2023). A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry. Asian Journal of Pharmaceutical Research and Development, 11(3), 45–51. https://doi.org/10.22270/ajprd.v11i3.1252

MLA 9

Laddha, C.S., et al. “A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry.” Asian Journal of Pharmaceutical Research and Development, vol. 11, no. 3, 2023, pp. 45–51. https://doi.org/10.22270/ajprd.v11i3.1252.

Chicago

Laddha, C.S., Ankita Shelke, Y.V. Vaidya, A.A. Sheikh, and Kailas R. Biyani. 2023. “A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry.” Asian Journal of Pharmaceutical Research and Development 11 (3): 45–51. https://doi.org/10.22270/ajprd.v11i3.1252.

Harvard

Laddha, C. et al. (2023) ‘A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry’, Asian Journal of Pharmaceutical Research and Development, 11(3), pp. 45–51. doi:10.22270/ajprd.v11i3.1252.

IEEE

C. Laddha, A. Shelke, Y. Vaidya, A. Sheikh, and K. R. Biyani, “A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry,” Asian Journal of Pharmaceutical Research and Development, vol. 11, no. 3, pp. 45–51, 2023, doi: 10.22270/ajprd.v11i3.1252.

BibTeX

@article{laddha2023review,
  title     = {{A Review on Artificial Intellegence in Drug Discovery \& Pharmaceutical Industry}},
  author    = {Laddha, C.S. and Shelke, Ankita and Vaidya, Y.V. and Sheikh, A.A. and Biyani, Kailas R.},
  journal   = {Asian Journal of Pharmaceutical Research and Development},
  year      = {2023},
  volume    = {11},
  number    = {3},
  pages     = {45--51},
  doi       = {10.22270/ajprd.v11i3.1252},
  url       = {https://doi.org/10.22270/ajprd.v11i3.1252}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence
  • drug discovery
  • pharmaceutical industry
  • machine learning
  • artificial neural networks
  • natural language processing
  • target identification
  • lead optimization

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Laddha, C., Shelke, A., Vaidya, Y., Sheikh, A., & Biyani, K. R. (2023). A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry. Asian Journal of Pharmaceutical Research and Development, 11(3), 45–51. https://doi.org/10.22270/ajprd.v11i3.1252

How many times has this paper been cited?

3 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Asian Journal of Pharmaceutical Research and Development.

Who wrote this paper?

C.S. Laddha, Ankita Shelke, Y.V. Vaidya, A.A. Sheikh, Kailas R. Biyani.

What is the DOI of this paper?

10.22270/ajprd.v11i3.1252. The permanent link is https://doi.org/10.22270/ajprd.v11i3.1252.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.